LabCorp Acquires MNG Laboratories from HealthEdge
March 4, 2019
LabCorp has acquired MNG Laboratories, an Atlanta-based clinical diagnostic provider specializing in neurogenetics and next-generation sequencing, from HealthEdge Investment Partners' Fund II. The acquisition expands LabCorp’s neurology and neurogenetics testing capabilities and makes MNG’s testing services available through LabCorp’s Covance drug development business.
- Buyers
- LabCorp
- Targets
- MNG Laboratories
- Sellers
- HealthEdge Investment Partners
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
WebMD Health Corp Acquires MNG Health
July 28, 2022
Healthcare Services
WebMD Health Corp., through its Medscape platform, acquired MNG Health, a provider of technology-enabled marketing solutions for life sciences brands. The deal expands Medscape's capabilities in virtual events, pharmaceutical sales-rep enablement, and omnichannel digital marketing; terms were not disclosed and MNG will operate as an independent Medscape subsidiary.
-
Labcorp Acquires Personal Genome Diagnostics (PGDx)
February 21, 2022
Healthcare Services
Labcorp has completed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a cancer genomics company focused on liquid biopsy and tissue-based genomic products and services. The deal builds on and expands Labcorp’s oncology and next-generation sequencing (NGS) capabilities and liquid biopsy offerings.
-
LabGenomics USA LLC Acquires QDx Pathology
September 5, 2023
Healthcare Services
LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.
-
MLM Medical Labs Acquires MD Biosciences, Inc.
October 27, 2020
Healthcare Services
MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.
-
NeoGenomics Acquires Pathline
April 7, 2025
Healthcare Services
NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.
-
LabGenomics USA Acquires Integrated Molecular Diagnostics (IMD) CLIA Labs
October 25, 2024
Healthcare Services
LabGenomics USA acquired Integrated Molecular Diagnostics (IMD) CLIA labs, expanding its U.S. footprint to four CLIA-certified laboratories and strengthening its molecular and oncology diagnostic capabilities. The deal broadens LabGenomics' geographic reach across the U.S. coasts and positions the company to launch new laboratory-developed tests (LDTs) and expand reimbursable services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.